Marco Galluzzo

2.5k total citations
86 papers, 1.4k citations indexed

About

Marco Galluzzo is a scholar working on Immunology, Dermatology and Physiology. According to data from OpenAlex, Marco Galluzzo has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 56 papers in Dermatology and 26 papers in Physiology. Recurrent topics in Marco Galluzzo's work include Psoriasis: Treatment and Pathogenesis (58 papers), Dermatology and Skin Diseases (53 papers) and Asthma and respiratory diseases (22 papers). Marco Galluzzo is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (58 papers), Dermatology and Skin Diseases (53 papers) and Asthma and respiratory diseases (22 papers). Marco Galluzzo collaborates with scholars based in Italy, Romania and Netherlands. Marco Galluzzo's co-authors include Marina Talamonti, Luca Bianchi, S. D’Adamio, Sergio Chimenti, Elena Campione, Antonio Costanzo, Miriam Teoli, Paul Lombardo, Mauro Bavetta and Clara De Simone and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Marco Galluzzo

79 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Galluzzo Italy 22 1.0k 720 305 212 207 86 1.4k
Zenas Z N Yiu United Kingdom 21 1.2k 1.2× 898 1.2× 286 0.9× 308 1.5× 198 1.0× 72 1.8k
Isabelle Hampele United States 6 1.3k 1.3× 751 1.0× 256 0.8× 344 1.6× 261 1.3× 8 1.6k
Melodie Young United States 15 1.0k 1.0× 575 0.8× 141 0.5× 223 1.1× 245 1.2× 41 1.3k
Sergio Chimenti Italy 23 1.2k 1.2× 896 1.2× 142 0.5× 268 1.3× 278 1.3× 53 1.7k
M. Lahfa France 15 933 0.9× 1.1k 1.5× 174 0.6× 235 1.1× 204 1.0× 22 1.6k
Dagmar Wilsmann‐Theis Germany 19 739 0.7× 677 0.9× 203 0.7× 155 0.7× 169 0.8× 68 1.1k
Marianne Notter Switzerland 5 1.3k 1.3× 732 1.0× 266 0.9× 342 1.6× 250 1.2× 9 1.6k
Norman Wasel Canada 14 1.6k 1.6× 949 1.3× 303 1.0× 388 1.8× 330 1.6× 20 2.0k
Annamaria Mazzotta Italy 16 756 0.7× 448 0.6× 129 0.4× 193 0.9× 110 0.5× 29 901
Luca Potestio Italy 25 778 0.8× 839 1.2× 207 0.7× 142 0.7× 220 1.1× 114 1.4k

Countries citing papers authored by Marco Galluzzo

Since Specialization
Citations

This map shows the geographic impact of Marco Galluzzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Galluzzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Galluzzo more than expected).

Fields of papers citing papers by Marco Galluzzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Galluzzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Galluzzo. The network helps show where Marco Galluzzo may publish in the future.

Co-authorship network of co-authors of Marco Galluzzo

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Galluzzo. A scholar is included among the top collaborators of Marco Galluzzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Galluzzo. Marco Galluzzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talamonti, Marina, et al.. (2025). Effects of Guselkumab on the FIB ‐4 Index in Psoriasis Patients ( EGIPT ): A Three‐Year Study. The Journal of Dermatology. 52(6). 1113–1117.
2.
Mastorino, Luca, Paolo Dapavo, Martina Burlando, et al.. (2025). Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years. PubMed. Volume 15. 339–350.
3.
Talamonti, Marina, et al.. (2024). Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study. Journal of Clinical Medicine. 13(7). 1876–1876. 4 indexed citations
4.
Raimondo, Cosimo Di, et al.. (2024). Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. International Journal of Molecular Sciences. 25(13). 7099–7099. 2 indexed citations
5.
Talamonti, Marina, et al.. (2024). Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience. Journal of Clinical Medicine. 13(17). 5175–5175. 4 indexed citations
6.
Amerio, Paolo, Silvia Mariel Ferrucci, Marco Galluzzo, et al.. (2024). A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis. Dermatology and Therapy. 14(6). 1443–1455. 4 indexed citations
7.
Galluzzo, Marco, Marina Talamonti, Luca Bianchi, et al.. (2024). Dupilumab-Associated Ocular Surface Disease or Atopic Keratoconjunctivitis Not Improved by Dupilumab? Upadacitinib May Clarify the Dilemma: A Case Report. SHILAP Revista de lepidopterología. 4(3). e354–e354. 2 indexed citations
8.
Talamonti, Marina, et al.. (2024). Eczematous liraglutide eruption managed by dupilumab: A case report. JAAD Case Reports. 53. 57–59. 2 indexed citations
9.
Campione, Elena, Marco Galluzzo, Caterina Lanna, et al.. (2023). A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients. Pharmaceuticals. 16(4). 526–526. 16 indexed citations
10.
Galluzzo, Marco, et al.. (2023). Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks. Expert Opinion on Biological Therapy. 23(4). 371–381. 12 indexed citations
11.
Galluzzo, Marco, et al.. (2023). Successful Long-Term Guselkumab Treatment of Severe Plaque Psoriasis in Patients with Class III Obesity: A Case Series. SHILAP Revista de lepidopterología. 4(1). e289–e289. 2 indexed citations
12.
Mazzilli, Sarah A., Alessandro Giunta, Marco Galluzzo, et al.. (2022). Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy. Italian Journal of Dermatology and Venereology. 156(6). 2 indexed citations
13.
Talamonti, Marina, et al.. (2021). Quality of Life and Psychological Impact in Patients with Atopic Dermatitis. Journal of Clinical Medicine. 10(6). 1298–1298. 36 indexed citations
14.
Galluzzo, Marco, et al.. (2020). Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study. Journal of Clinical Medicine. 9(7). 2170–2170. 58 indexed citations
15.
Galluzzo, Marco, S. D’Adamio, Maria Sole Chimenti, et al.. (2019). Successful treatment of psoriatic crumbly nails with ustekinumab. Dermatologic Therapy. 32(3). e12914–e12914. 4 indexed citations
16.
Ventura, Alessandra, et al.. (2017). New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug Design Development and Therapy. Volume 11. 2527–2535. 44 indexed citations
17.
Talamonti, Marina, S. D’Adamio, Luca Bianchi, & Marco Galluzzo. (2017). The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature. Molecular Diagnosis & Therapy. 21(5). 467–480. 16 indexed citations
18.
Galluzzo, Marco, Andreea Boca, Elisabetta Botti, et al.. (2015). IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis. Dermatology. 232(2). 230–236. 40 indexed citations
19.
Galluzzo, Marco, Marina Talamonti, Alessandro Di Stefani, & Sergio Chimenti. (2015). Linear psoriasis following the typical distribution of the sciatic nerve. Journal of Dermatological Case Reports. 9(1). 6–11. 6 indexed citations
20.
Talamonti, Marina, Marco Galluzzo, Luca Bianchi, et al.. (2014). What Happened after the Clinical Trials: Long-Term Safety and Efficacy of Ustekinumab in Daily Clinical Practice. Dermatology. 229(4). 324–332. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zenas Z N Yiu Breakdown of academic impact, for papers by Isabelle Hampele Breakdown of academic impact, for papers by Melodie Young Breakdown of academic impact, for papers by Sergio Chimenti Breakdown of academic impact, for papers by M. Lahfa Breakdown of academic impact, for papers by Dagmar Wilsmann‐Theis Breakdown of academic impact, for papers by Marianne Notter Breakdown of academic impact, for papers by Norman Wasel Breakdown of academic impact, for papers by Annamaria Mazzotta Breakdown of academic impact, for papers by Luca Potestio
Rankless by CCL
2026